NEQAS sets Stage for new UK Division

Molecular diagnostics products manufacturer HiberGene Diagnostics is to supply its point-of-care (POC) and near-patient testing solutions directly to healthcare providers in the UK and Ireland.

The Dublin-based company’s test solutions which cover infectious and transmissible disease areas - including respiratory, sexually transmitted infections, hospital acquired infections and women’s health – have been designed for improved turnaround in result times in almost any setting, bringing cost and time savings along with improved patient management.

Complementing the opening of its UK division, HiberGene were sponsors of UK NEQAS’ multi-disciplinary event ‘Supporting your point of care testing (POCT) service’ held at the Hyatt Regency Hotel in Birmingham on 30 June 2022. At the one-day seminar the company took part in key discussions on accrediting and implementing these services in a healthcare setting and the benefits that this can bring for both patients and clinicians.

David Corr CEO of HiberGene said : “After immense success in Ireland, we are excited to announce the launch of our new, dedicated UK team, increasing our geographical reach and capabilities for our growing customer base. Our multi-disciplinary teams possess deep technical knowledge on a wide variety of testing options to deliver the best solution for each customer enjoyed showcasing their knowledge in key discussions at the UK NEQAS event.”

More information online